This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Mayo Foundation for Medical Education and Research. Active years: 2020-2022.
Company Filing History:
Years Active: 2020-2022
Title: Scott M Riester: Innovator in Rotator Cuff Treatment
Introduction
Scott M Riester is a notable inventor based in Rochester, MN (US). He has made significant contributions to the field of medical treatment, particularly focusing on rotator cuff conditions. With a total of three patents to his name, Riester's work is paving the way for innovative solutions in orthopedic medicine.
Latest Patents
Riester's latest patents include methods and materials related to treating rotator cuff conditions, such as rotator cuff tendonitis and partial rotator cuff tears. One of his patents discusses the use of zinc or a zinc chelator as a treatment option for these conditions. Another patent outlines methods for utilizing BMP-5 polypeptides and inhibitors of SIRT6, SIRT7, and/or HDAC10 polypeptide expression or activity to address rotator cuff issues. These advancements highlight his commitment to improving patient outcomes in orthopedic care.
Career Highlights
Scott M Riester is affiliated with the Mayo Foundation for Medical Education and Research, where he continues to develop and refine his innovative approaches to medical treatment. His work is characterized by a strong focus on research and practical applications that can benefit patients suffering from rotator cuff injuries.
Collaborations
Throughout his career, Riester has collaborated with esteemed colleagues, including John W Sperling and Andre J Van Wijnen. These partnerships have fostered a collaborative environment that enhances the development of new treatment methodologies.
Conclusion
Scott M Riester is a dedicated inventor whose work in treating rotator cuff conditions is making a significant impact in the medical field. His innovative patents and collaborations reflect his commitment to advancing orthopedic treatment options.